D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter and Full Year 2024 Results Call. All participants will be in listen-only ...

Capital One Financial Corporation (COF), a financial services company, has gained more than 31% over the past year. Yesterday, BTIG ...

You can also check out our list of best credit cards for alternative options. The Capital One Savor Student Cash Rewards Credit Card gives college students a great option to earn cash back ...

Evercore ISI analyst John Pancari upgraded Capital One (COF) to Outperform from In Line with an unchanged price target of $200. The firm ...

Commissions do not affect our editors' opinions or evaluations. Capital One combines the convenience of online banking with the reach of a traditional bank. It’s known for its competitive ...

Straiker, an AI-native security company, announced its launch from stealth mode today with $21 million in initial funding from Lightspeed Ventures and Bain Capital Ventures. Straiker is introducing ...

Capital One offers some of the best cash-back and rewards credit cards for consumers and small business owners. The Capital One Savor Cash Rewards Credit Card and Capital One Venture Rewards ...

Although the similar logos and names can confuse consumers when it comes to distinguishing between Credit One and Capital One, the two credit card issuers are not related. Credit Score ranges are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Other large contractors such as Suffolk Construction and DPR Construction have started their own venture capital arms in recent years. Turner's relative position as the largest contractor by ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time gene therapy for the treatment of patients with vision loss due to a ...